Eurizon Capital SGR SpA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1M Sell
67,351
-81,057
-55% -$30.1M 0.07% 218
2026
Q1
$43.4M Sell
148,408
-39,673
-21% -$13M 0.14% 146
2025
Q4
$65.9M Buy
+188,081
New +$63.6M 0.21% 100

Other funds holding ELV

Eurizon Capital SGR SpA's ELV Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Elevance Health (ELV) stake by 55% in Q2 2026, selling an estimated $30.1M and leaving 67,351 shares worth $26.1M. The position accounts for 0.07% of the portfolio, ranked #218.

Eurizon Capital SGR SpA first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $65.9M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Eurizon Capital SGR SpA held 67,351 shares of Elevance Health worth $26.1M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 81,057 Elevance Health shares in Q2 2026, an estimated $30.1M.
  • Elevance Health made up 0.07% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #218 holding.
  • Eurizon Capital SGR SpA first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Elevance Health position peaked at $65.9M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.